Similar Posts
How Cannabinoids Quell Anxiety
ByOSadminThis article originally appeared at https://thefreshtoast.com/cannabis/how-do-cannabinoids-quell-anxiety Cannabis has powerful anxiolytic (anti-anxiety) properties, and when administered as-needed, can provide relief from several anxiety disorders. Anxiety, like marijuana, comes with a stigma, but with the increasing impact of anxiety disorders on family life and the economy, it’s no wonder everyone seems to be looking for a salve….
Medical Cannabis Patients Report Improvements in Health Functioning and Reductions in Opiate Use
ByOSadminThis article originally appeared at https://www.tandfonline.com/doi/full/10.1080/10826084.2022.2107673 Abstract Purpose: Opioid use rates have dropped as North American patients gain access to medical cannabis, indicating a harm reduction role, yet health outcomes remain mostly unexplored. This study presents self-reported medical cannabis use, perceptions of health functioning, and changes in opioid pain medication use in Florida medical cannabis…
No evidence to suggest cannabis use causes schizophrenia-so why do some people think it does?
ByOSadminThis originally appeared at https://www.ualberta.ca/folio/2018/10/commentary–no-evidence-to-suggest-cannabis-use-causes-schizophreniaso-why-do-some-people-think-it-does.html U of A psychology professor explains how the myth began and why it isn’t true. October 05, 2018 By Tim Parker For parents of individuals who have been diagnosed with schizophrenia, one of the most troubling questions must be, “Did my child develop schizophrenia because they consumed cannabis?” Certainly, this…
Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence
ByOSadminThis originally appeared at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753886/ Am J Addict. Author manuscript; available in PMC 2009 Sep 29. Published in final edited form as: Am J Addict. 2009 Jul–Aug; 18(4): 301–308. doi: 10.1080/10550490902927785PMCID: PMC2753886NIHMSID: NIHMS141953PMID: 19444734 Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence Wilfrid Noel Raby, PhD, MD, Kenneth M. Carpenter, PhD, Jami Rothenberg, PhD, Adam C. Brooks, PhD, Huiping…
Associations between adolescent cannabis use and neuropsychological decline: a longitudinal co-twin control study
ByOSadminThis originally appeared at https://onlinelibrary.wiley.com/doi/abs/10.1111/add.13946 Madeline H. Meier, Avshalom Caspi, Andrea Danese, Helen L. Fisher, Renate Houts, Louise Arseneault, Terrie E. Moffitt First published: 22 July 2017 https://doi.org/10.1111/add.13946 Abstract Aims This study tested whether adolescents who used cannabis or met criteria for cannabis dependence showed neuropsychological impairment prior to cannabis initiation and neuropsychological decline from before to after cannabis initiation. Design…
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells
ByOSadminThis article originally appeared at https://gut.bmj.com/content/54/12/1741.abstract Authors: Abstract Background and aims: Cyclooxygenase 2 (COX-2) is upregulated in most colorectal cancers and is responsible for metabolism of the endogenous cannabinoid, anandamide, into prostaglandin-ethanolamides (PG-EAs). The aims of this study were to determine whether anandamide and PG-EAs induce cell death in colorectal carcinoma (CRC) cells, and whether high…
